During the past decade, The Second Affiliated Hospital of Nanjing Medical University conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 6 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 6 clinical trials were completed. i.e. 14.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Nanjing Medical University" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Bayer" with 4 trials sponsored, "The Second Hospital of Nanjing Medical University" with 4 trials sponsored, "Xiamen Amoytop Biotech Co., Ltd." with 4 trials sponsored and "Nanfang Hospital of Southern Medical University" with 4 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Nanjing Medical University" #1 collaborator was "The Second Hospital of Nanjing Medical University" with 3 trials as a collaborator, "Tigermed Consulting Co., Ltd" with 3 trials as a collaborator, "Jiangsu Yuyue medical equipment & supply Co., Ltd." with 2 trials as a collaborator, "Nanjing Medical University" with 2 trials as a collaborator and "Peking University First Hospital" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Nanjing Medical University" are "Hepatitis B, Chronic" (7 trials), "Chronic Hepatitis B" (6 trials), "Obesity" (6 trials), "Type 2 Diabetes" (4 trials) and "Chronic Hepatitis C" (3 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Nanjing Medical University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Nanjing Medical University" are "Drug" (60 trials), "Other" (6 trials), "Procedure" (5 trials), "Device" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Tirzepatide" (7 trials), "Ypeginterferon alfa-2b" (4 trials), "Lamivudine" (3 trials) and "Adefovir" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Nanjing Medical University" are 73 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "The Second Affiliated Hospital of Nanjing Medical University". 3 are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in The Second Affiliated Hospital of Nanjing Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Nanjing Medical University, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 12 trials that are defined as “Not Applicable".